aluates Reports

$ 0.0

Automative

Global Vaccinia Virus (VACV) Service Market Research Report 2024

Published Date: December 2024

Report Code: QYRE-Auto-20U18904

BUY CHAPTERS

Global Vaccinia Virus (VACV) Service Market Research Report 2024

Code: QYRE-Auto-20U18904

Report

December 2024

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

VectorBuilder

Creative-Biolabs

Creative Biogene

Esco Aster Pte. Ltd

Sementis

Genevoyager (Wuhan) Co., Ltd.

Vaccinia Virus (VACV) Service Market Size

The global market for Vaccinia Virus (VACV) Service was valued at US$ 74.1 million in the year 2023 and is projected to reach a revised size of US$ 153 million by 2030, growing at a CAGR of 9.7% during the forecast period.

Vaccinia Virus (VACV) Service Market

Vaccinia virus (VACV or VV) is the most widely used viral vector for the study of exogenous gene expression and immunogenicity of the resulting protein. Replication-competent recombinant VACV-based vaccines have received increasing attention as potential vaccine vectors for many infectious diseases, as they may be able to elicit potent humoral and cell-mediated immune responses and long-lasting protection.Vaccinia virus (VACV) is a large enveloped, double-stranded DNA virus in the genus of Orthopoxvirus of the family Poxviridae. The VACV genome is comprised of approximately 190,000 nucleotides which encodes approximately 250 genes. VACV is one of the most commonly developed oncolytic vectors. There are several features make VACV a promising oncolytic vector which include excellent lytic activity, natural and broad tumor tropism as well as well-known and easy-manipulating genome structure etc.

North American market for Vaccinia Virus (VACV) Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Vaccinia Virus (VACV) Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Vaccinia Virus (VACV) Service in Scientific Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Vaccinia Virus (VACV) Service include VectorBuilder, Creative Biolabs, Creative Biogene, Genevoyager (Wuhan) Co., Ltd., Esco Aster Pte. Ltd., Sementis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Vaccinia Virus (VACV) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccinia Virus (VACV) Service.

The Vaccinia Virus (VACV) Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccinia Virus (VACV) Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Vaccinia Virus (VACV) Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Vaccinia Virus (VACV) Service Market Report

Report Metric	Details
Report Name	Vaccinia Virus (VACV) Service Market
Accounted market size in year	US$ 74.1 million
Forecasted market size in 2030	US$ 153 million
CAGR	9.7%
Base Year	year
Forecasted years	2025 - 2030
Segment by Type	Attenuated Vaccinia Virus Recombinant Vaccinia Virus Other
Segment by Application	Scientific Research Vaccine Development Oncolytic Therapy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	VectorBuilder, Creative Biolabs, Creative Biogene, Genevoyager (Wuhan) Co., Ltd., Esco Aster Pte. Ltd., Sementis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccinia Virus (VACV) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Vaccinia Virus (VACV) Service Market growing?

Ans: The Vaccinia Virus (VACV) Service Market witnessing a CAGR of 9.7% during the forecast period 2025-2030.

What is the Vaccinia Virus (VACV) Service Market size in 2030?

Ans: The Vaccinia Virus (VACV) Service Market size in 2030 will be US$ 153 million.

Who are the main players in the Vaccinia Virus (VACV) Service Market report?

Ans: The main players in the Vaccinia Virus (VACV) Service Market are VectorBuilder, Creative Biolabs, Creative Biogene, Genevoyager (Wuhan) Co., Ltd., Esco Aster Pte. Ltd., Sementis

What are the Application segmentation covered in the Vaccinia Virus (VACV) Service Market report?

Ans: The Applications covered in the Vaccinia Virus (VACV) Service Market report are Scientific Research, Vaccine Development, Oncolytic Therapy

What are the Type segmentation covered in the Vaccinia Virus (VACV) Service Market report?

Ans: The Types covered in the Vaccinia Virus (VACV) Service Market report are Attenuated Vaccinia Virus, Recombinant Vaccinia Virus, Other

Recommended Reports

Vaccinia and Viral Vectors

Vaccines and Adjuvants

Genetically Engineered Vaccines

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Vaccinia Virus (VACV) Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Attenuated Vaccinia Virus

1.2.3 Recombinant Vaccinia Virus

1.2.4 Other

1.3 Market by Application

1.3.1 Global Vaccinia Virus (VACV) Service Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Scientific Research

1.3.3 Vaccine Development

1.3.4 Oncolytic Therapy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Vaccinia Virus (VACV) Service Market Perspective (2019-2030)

2.2 Global Vaccinia Virus (VACV) Service Growth Trends by Region

2.2.1 Global Vaccinia Virus (VACV) Service Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Vaccinia Virus (VACV) Service Historic Market Size by Region (2019-2024)

2.2.3 Vaccinia Virus (VACV) Service Forecasted Market Size by Region (2025-2030)

2.3 Vaccinia Virus (VACV) Service Market Dynamics

2.3.1 Vaccinia Virus (VACV) Service Industry Trends

2.3.2 Vaccinia Virus (VACV) Service Market Drivers

2.3.3 Vaccinia Virus (VACV) Service Market Challenges

2.3.4 Vaccinia Virus (VACV) Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Vaccinia Virus (VACV) Service Players by Revenue

3.1.1 Global Top Vaccinia Virus (VACV) Service Players by Revenue (2019-2024)

3.1.2 Global Vaccinia Virus (VACV) Service Revenue Market Share by Players (2019-2024)

3.2 Global Vaccinia Virus (VACV) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Vaccinia Virus (VACV) Service Revenue

3.4 Global Vaccinia Virus (VACV) Service Market Concentration Ratio

3.4.1 Global Vaccinia Virus (VACV) Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Vaccinia Virus (VACV) Service Revenue in 2023

3.5 Global Key Players of Vaccinia Virus (VACV) Service Head office and Area Served

3.6 Global Key Players of Vaccinia Virus (VACV) Service, Product and Application

3.7 Global Key Players of Vaccinia Virus (VACV) Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Vaccinia Virus (VACV) Service Breakdown Data by Type

4.1 Global Vaccinia Virus (VACV) Service Historic Market Size by Type (2019-2024)

4.2 Global Vaccinia Virus (VACV) Service Forecasted Market Size by Type (2025-2030)

5 Vaccinia Virus (VACV) Service Breakdown Data by Application

5.1 Global Vaccinia Virus (VACV) Service Historic Market Size by Application (2019-2024)

5.2 Global Vaccinia Virus (VACV) Service Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Vaccinia Virus (VACV) Service Market Size (2019-2030)

6.2 North America Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Vaccinia Virus (VACV) Service Market Size by Country (2019-2024)

6.4 North America Vaccinia Virus (VACV) Service Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Vaccinia Virus (VACV) Service Market Size (2019-2030)

7.2 Europe Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Vaccinia Virus (VACV) Service Market Size by Country (2019-2024)

7.4 Europe Vaccinia Virus (VACV) Service Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Vaccinia Virus (VACV) Service Market Size (2019-2030)

8.2 Asia-Pacific Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2019-2024)

8.4 Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Vaccinia Virus (VACV) Service Market Size (2019-2030)

9.2 Latin America Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Vaccinia Virus (VACV) Service Market Size by Country (2019-2024)

9.4 Latin America Vaccinia Virus (VACV) Service Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Vaccinia Virus (VACV) Service Market Size (2019-2030)

10.2 Middle East & Africa Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2019-2024)

10.4 Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 VectorBuilder

11.1.1 VectorBuilder Company Details

11.1.2 VectorBuilder Business Overview

11.1.3 VectorBuilder Vaccinia Virus (VACV) Service Introduction

11.1.4 VectorBuilder Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)

11.1.5 VectorBuilder Recent Development

11.2 Creative Biolabs

11.2.1 Creative Biolabs Company Details

11.2.2 Creative Biolabs Business Overview

11.2.3 Creative Biolabs Vaccinia Virus (VACV) Service Introduction

11.2.4 Creative Biolabs Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)

11.2.5 Creative Biolabs Recent Development

11.3 Creative Biogene

11.3.1 Creative Biogene Company Details

11.3.2 Creative Biogene Business Overview

11.3.3 Creative Biogene Vaccinia Virus (VACV) Service Introduction

11.3.4 Creative Biogene Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)

11.3.5 Creative Biogene Recent Development

11.4 Genevoyager (Wuhan) Co., Ltd.

11.4.1 Genevoyager (Wuhan) Co., Ltd. Company Details

11.4.2 Genevoyager (Wuhan) Co., Ltd. Business Overview

11.4.3 Genevoyager (Wuhan) Co., Ltd. Vaccinia Virus (VACV) Service Introduction

11.4.4 Genevoyager (Wuhan) Co., Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)

11.4.5 Genevoyager (Wuhan) Co., Ltd. Recent Development

11.5 Esco Aster Pte. Ltd.

11.5.1 Esco Aster Pte. Ltd. Company Details

11.5.2 Esco Aster Pte. Ltd. Business Overview

11.5.3 Esco Aster Pte. Ltd. Vaccinia Virus (VACV) Service Introduction

11.5.4 Esco Aster Pte. Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)

11.5.5 Esco Aster Pte. Ltd. Recent Development

11.6 Sementis

11.6.1 Sementis Company Details

11.6.2 Sementis Business Overview

11.6.3 Sementis Vaccinia Virus (VACV) Service Introduction

11.6.4 Sementis Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)

11.6.5 Sementis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

VectorBuilder

Creative-Biolabs

Creative Biogene

Esco Aster Pte. Ltd

Sementis

Genevoyager (Wuhan) Co., Ltd.

List of Tables

Table 1. Global Vaccinia Virus (VACV) Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Attenuated Vaccinia Virus

Table 3. Key Players of Recombinant Vaccinia Virus

Table 4. Key Players of Other

Table 5. Global Vaccinia Virus (VACV) Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Vaccinia Virus (VACV) Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Vaccinia Virus (VACV) Service Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Vaccinia Virus (VACV) Service Market Share by Region (2019-2024)

Table 9. Global Vaccinia Virus (VACV) Service Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Vaccinia Virus (VACV) Service Market Share by Region (2025-2030)

Table 11. Vaccinia Virus (VACV) Service Market Trends

Table 12. Vaccinia Virus (VACV) Service Market Drivers

Table 13. Vaccinia Virus (VACV) Service Market Challenges

Table 14. Vaccinia Virus (VACV) Service Market Restraints

Table 15. Global Vaccinia Virus (VACV) Service Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Vaccinia Virus (VACV) Service Market Share by Players (2019-2024)

Table 17. Global Top Vaccinia Virus (VACV) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccinia Virus (VACV) Service as of 2023)

Table 18. Ranking of Global Top Vaccinia Virus (VACV) Service Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Vaccinia Virus (VACV) Service Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Vaccinia Virus (VACV) Service, Headquarters and Area Served

Table 21. Global Key Players of Vaccinia Virus (VACV) Service, Product and Application

Table 22. Global Key Players of Vaccinia Virus (VACV) Service, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Vaccinia Virus (VACV) Service Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Vaccinia Virus (VACV) Service Revenue Market Share by Type (2019-2024)

Table 26. Global Vaccinia Virus (VACV) Service Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Vaccinia Virus (VACV) Service Revenue Market Share by Type (2025-2030)

Table 28. Global Vaccinia Virus (VACV) Service Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Vaccinia Virus (VACV) Service Revenue Market Share by Application (2019-2024)

Table 30. Global Vaccinia Virus (VACV) Service Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Vaccinia Virus (VACV) Service Revenue Market Share by Application (2025-2030)

Table 32. North America Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Vaccinia Virus (VACV) Service Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Vaccinia Virus (VACV) Service Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Vaccinia Virus (VACV) Service Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Vaccinia Virus (VACV) Service Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Vaccinia Virus (VACV) Service Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Vaccinia Virus (VACV) Service Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2025-2030) & (US$ Million)

Table 47. VectorBuilder Company Details

Table 48. VectorBuilder Business Overview

Table 49. VectorBuilder Vaccinia Virus (VACV) Service Product

Table 50. VectorBuilder Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)

Table 51. VectorBuilder Recent Development

Table 52. Creative Biolabs Company Details

Table 53. Creative Biolabs Business Overview

Table 54. Creative Biolabs Vaccinia Virus (VACV) Service Product

Table 55. Creative Biolabs Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)

Table 56. Creative Biolabs Recent Development

Table 57. Creative Biogene Company Details

Table 58. Creative Biogene Business Overview

Table 59. Creative Biogene Vaccinia Virus (VACV) Service Product

Table 60. Creative Biogene Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)

Table 61. Creative Biogene Recent Development

Table 62. Genevoyager (Wuhan) Co., Ltd. Company Details

Table 63. Genevoyager (Wuhan) Co., Ltd. Business Overview

Table 64. Genevoyager (Wuhan) Co., Ltd. Vaccinia Virus (VACV) Service Product

Table 65. Genevoyager (Wuhan) Co., Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)

Table 66. Genevoyager (Wuhan) Co., Ltd. Recent Development

Table 67. Esco Aster Pte. Ltd. Company Details

Table 68. Esco Aster Pte. Ltd. Business Overview

Table 69. Esco Aster Pte. Ltd. Vaccinia Virus (VACV) Service Product

Table 70. Esco Aster Pte. Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)

Table 71. Esco Aster Pte. Ltd. Recent Development

Table 72. Sementis Company Details

Table 73. Sementis Business Overview

Table 74. Sementis Vaccinia Virus (VACV) Service Product

Table 75. Sementis Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)

Table 76. Sementis Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. Vaccinia Virus (VACV) Service Picture

Figure 2. Global Vaccinia Virus (VACV) Service Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Vaccinia Virus (VACV) Service Market Share by Type: 2023 VS 2030

Figure 4. Attenuated Vaccinia Virus Features

Figure 5. Recombinant Vaccinia Virus Features

Figure 6. Other Features

Figure 7. Global Vaccinia Virus (VACV) Service Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Vaccinia Virus (VACV) Service Market Share by Application: 2023 VS 2030

Figure 9. Scientific Research Case Studies

Figure 10. Vaccine Development Case Studies

Figure 11. Oncolytic Therapy Case Studies

Figure 12. Vaccinia Virus (VACV) Service Report Years Considered

Figure 13. Global Vaccinia Virus (VACV) Service Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Vaccinia Virus (VACV) Service Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Vaccinia Virus (VACV) Service Market Share by Region: 2023 VS 2030

Figure 16. Global Vaccinia Virus (VACV) Service Market Share by Players in 2023

Figure 17. Global Top Vaccinia Virus (VACV) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccinia Virus (VACV) Service as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Vaccinia Virus (VACV) Service Revenue in 2023

Figure 19. North America Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Vaccinia Virus (VACV) Service Market Share by Country (2019-2030)

Figure 21. United States Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Vaccinia Virus (VACV) Service Market Share by Country (2019-2030)

Figure 25. Germany Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Vaccinia Virus (VACV) Service Market Share by Region (2019-2030)

Figure 33. China Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Vaccinia Virus (VACV) Service Market Share by Country (2019-2030)

Figure 41. Mexico Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Vaccinia Virus (VACV) Service Market Share by Country (2019-2030)

Figure 45. Turkey Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. VectorBuilder Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)

Figure 49. Creative Biolabs Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)

Figure 50. Creative Biogene Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)

Figure 51. Genevoyager (Wuhan) Co., Ltd. Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)

Figure 52. Esco Aster Pte. Ltd. Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)

Figure 53. Sementis Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Recombinant Vector Vaccines Market Insights Forecast to 2030

Global Adenovirus Services Market Research Report 2025

Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncolytic Virus Market Insights Forecast to 2030

Global Smallpox Vaccine Market Research Report 2024

Adenovirus Vector Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncolytic Virus Therapy Market Research Report 2025

Global Viral Vectors Gene Therapy Market Research Report 2025

Global Avian Pox Vaccine Market Research Report 2024

Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monkeypox Vaccine Market Research Report 2025

Global Oncolytic Virus Cancer Immunotherapy Market Insights Forecast to 2030

Global Oncolytic Virus Immunotherapy Market Research Report 2024

Global Viral Vector Purification Market Research Report 2025

Global DNA Vaccines Market Insights Forecast to 2030

Viral Vector Production Research use Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Viral Vector and Plasmid DNA Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions